[HTML][HTML] Therapeutic effects of selective p300 histone acetyl-transferase inhibitor on liver fibrosis
H Kim, SY Park, SY Lee, JH Kwon, S Byun, MJ Kim… - BMB …, 2023 - ncbi.nlm.nih.gov
Liver fibrosis is caused by chronic liver damage and results in the aberrant accumulation of
extracellular matrix during disease progression. Despite the identification of the HAT …
extracellular matrix during disease progression. Despite the identification of the HAT …
[HTML][HTML] Pharmacological inhibition of p300 ameliorates steatosis, inflammation, and fibrosis in mice with non-alcoholic steatohepatitis
JY Kim, AY Yang, K Kim, HH Kwon, J Leem, YA Kim - Heliyon, 2024 - cell.com
The histone acetyltransferase p300 plays a pivotal role in regulating gene expression and
cellular phenotype through epigenetic mechanisms. It significantly influences lipid …
cellular phenotype through epigenetic mechanisms. It significantly influences lipid …
Perturbation of specific signaling pathways is involved in initiation of mouse liver fibrosis
L Chen, P Guo, W Li, F Fang, W Zhu, J Fan… - …, 2021 - Wiley Online Library
Background and Aims To identify the regulatory role of protein phosphatase 2A (PP2A) in
the development of liver disease, we generated a mouse model with hepatocyte‐specific …
the development of liver disease, we generated a mouse model with hepatocyte‐specific …
Dual pharmacological targeting of HDACs and PDE5 inhibits liver disease progression in a mouse model of biliary inflammation and fibrosis
A Claveria-Cabello, L Colyn, I Uriarte, MU Latasa… - Cancers, 2020 - mdpi.com
Simple Summary Chronic liver injury and inflammation leads to excessive deposition of
extracellular matrix, known as liver fibrosis, and the distortion of the hepatic parenchyma …
extracellular matrix, known as liver fibrosis, and the distortion of the hepatic parenchyma …
LP340, a novel histone deacetylase inhibitor, decreases liver injury and fibrosis in mice: role of oxidative stress and microRNA-23a
DJ Samuvel, JJ Lemasters, CJ Chou… - Frontiers in …, 2024 - frontiersin.org
Effective therapy for liver fibrosis is lacking. Here, we examined whether LP340, the lead
candidate of a new-generation of hydrazide-based HDAC1, 2, 3 inhibitors (HDACi) …
candidate of a new-generation of hydrazide-based HDAC1, 2, 3 inhibitors (HDACi) …
[HTML][HTML] The role of p53 in liver fibrosis
S Yu, G Ji, L Zhang - Frontiers in Pharmacology, 2022 - frontiersin.org
The tumor suppressor p53 is the central hub of a molecular network, which controls cell
proliferation and death, and also plays an important role in the occurrence and development …
proliferation and death, and also plays an important role in the occurrence and development …
14-kDa phosphohistidine phosphatase is a potential therapeutic target for liver fibrosis
A Xu, J Zhou, Y Li, L Qiao, C Jin… - American Journal …, 2021 - journals.physiology.org
Liver fibrosis, a major cause of morbidity and mortality worldwide, leads to liver damage,
seriously threatening human health. In our previous study, we demonstrated that 14 kDa …
seriously threatening human health. In our previous study, we demonstrated that 14 kDa …
HAstening the development of liver fibrosis
K Ray - Nature Reviews Gastroenterology & Hepatology, 2019 - nature.com
New experimental research has demonstrated that hyaluronan (HA), a component of the
extracellular matrix, is involved in the development of liver fibrosis, with hyaluronan synthase …
extracellular matrix, is involved in the development of liver fibrosis, with hyaluronan synthase …
Parathyroid hormone-related protein activates HSCs via hedgehog signalling during liver fibrosis development
S He, J Tang, N Diao, Y Liao, J Shi, X Xu… - Artificial Cells …, 2019 - Taylor & Francis
Recently, we showed that parathyroid hormone-like hormone (PTHLH), a cytokine-like
polyprotein, is critical for extracellular matrix (ECM) deposition through the activation of …
polyprotein, is critical for extracellular matrix (ECM) deposition through the activation of …
A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells
KC Park, JH Park, JY Jeon, SY Kim… - British Journal of …, 2014 - Wiley Online Library
Background and Purpose Activation of hepatic stellate cells (HSCs) is a crucial step in the
pathogenesis of hepatic fibrosis. Histone deacetylase (HDAC) is an attractive target in liver …
pathogenesis of hepatic fibrosis. Histone deacetylase (HDAC) is an attractive target in liver …
相关搜索
- liver fibrosis p300 histone
- liver fibrosis therapeutic effects
- therapeutic effects p300 histone
- liver fibrosis acetyl transferase
- acetyl transferase p300 histone
- therapeutic effects acetyl transferase
- liver fibrosis inhibitors of class
- liver fibrosis bdl rats
- liver fibrosis phosphohistidine phosphatase
- liver fibrosis hepatic type